fda compounding semaglutide enforcement october 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our FDA Warns Companies Over Compounded

The solution is counterintuitive: reduce stress, sleep more, drop training volume slightly, and sometimes eat slightly more for a few days

Whether youre on your first shot or your fifteenth, understanding your B12 form matters

When you're dealing with chronic pain or a slow-healing injury, the promise of rapid recovery can be incredibly tempting

Almond, soy, and rice milk are not so high in vitamin B12

00:01:45 Vickie Danaher But this means that we now have multiple different FDA approved semaglutide products that we may get prescriptions for or that our patients may be getting or asking about

doi:10.1124/jpet.102.037481